Thursday, August 25, 2016

BRIEF-Neuroderm initiates patient enrollment in a phase III trial of ND0612l for treatment of Parkinson's disease

* Neuroderm initiates patient enrollment in a phase iii

trial of nd0612l for treatment of parkinson's disease

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)